The global economic burden of noncommunicable diseases DE Bloom, E Cafiero, E Jané-Llopis, S Abrahams-Gessel, LR Bloom, ... PGDA Working Papers, 2012 | 3480 | 2012 |
Carotid plaque MRI and stroke risk: a systematic review and meta-analysis A Gupta, H Baradaran, AD Schweitzer, H Kamel, A Pandya, D Delgado, ... Stroke 44 (11), 3071-3077, 2013 | 577 | 2013 |
Cerebrovascular reserve and stroke risk in patients with carotid stenosis or occlusion: a systematic review and meta-analysis A Gupta, JL Chazen, M Hartman, D Delgado, N Anumula, H Shao, ... Stroke 43 (11), 2884-2891, 2012 | 382 | 2012 |
Cost-effectiveness of 10-year risk thresholds for initiation of statin therapy for primary prevention of cardiovascular disease A Pandya, S Sy, S Cho, MC Weinstein, TA Gaziano Jama 314 (2), 142-150, 2015 | 257 | 2015 |
Silent brain infarction and risk of future stroke: a systematic review and meta-analysis A Gupta, AE Giambrone, G Gialdini, C Finn, D Delgado, J Gutierrez, ... Stroke 47 (3), 719-725, 2016 | 239 | 2016 |
Cardiac magnetic resonance stress perfusion imaging for evaluation of patients with chest pain RY Kwong, Y Ge, K Steel, S Bingham, S Abdullah, K Fujikura, W Wang, ... Journal of the American College of Cardiology 74 (14), 1741-1755, 2019 | 198 | 2019 |
More Americans living longer with cardiovascular disease will increase costs while lowering quality of life A Pandya, TA Gaziano, MC Weinstein, D Cutler Health Affairs 32 (10), 1706-1714, 2013 | 89 | 2013 |
A comparative assessment of non-laboratory-based versus commonly used laboratory-based cardiovascular disease risk scores in the NHANES III population A Pandya, MC Weinstein, TA Gaziano PloS one 6 (5), e20416, 2011 | 80 | 2011 |
Estimating (quality‐adjusted) life‐year losses associated with deaths: With application to COVID‐19 AH Briggs, DA Goldstein, E Kirwin, R Meacock, A Pandya, DJ Vanness, ... Health Economics 30 (3), 699-707, 2021 | 76 | 2021 |
Cost-effectiveness analysis of stress cardiovascular magnetic resonance imaging for stable chest pain syndromes Y Ge, A Pandya, K Steel, S Bingham, M Jerosch-Herold, YY Chen, ... Cardiovascular Imaging 13 (7), 1505-1517, 2020 | 70 | 2020 |
Bayesian methods for calibrating health policy models: a tutorial NA Menzies, DI Soeteman, A Pandya, JJ Kim Pharmacoeconomics 35 (6), 613-624, 2017 | 68 | 2017 |
Comparative effectiveness of personalized lifestyle management strategies for cardiovascular disease risk reduction P Chu, A Pandya, JA Salomon, SJ Goldie, MGM Hunink Journal of the American Heart Association 5 (3), e002737, 2016 | 68 | 2016 |
Evaluation of computed tomography angiography plaque thickness measurements in high-grade carotid artery stenosis A Gupta, H Baradaran, H Kamel, A Pandya, A Mangla, A Dunning, ... Stroke 45 (3), 740-745, 2014 | 68 | 2014 |
Oxygen extraction fraction and stroke risk in patients with carotid stenosis or occlusion: a systematic review and meta-analysis A Gupta, H Baradaran, AD Schweitzer, H Kamel, A Pandya, D Delgado, ... American Journal of Neuroradiology 35 (2), 250-255, 2014 | 65 | 2014 |
Adding cost-effectiveness to define low-value care A Pandya Jama 319 (19), 1977-1978, 2018 | 61 | 2018 |
Cost‐effectiveness of posaconazole versus fluconazole or itraconazole in the prevention of invasive fungal infections among neutropenic patients in the United States AK O'Sullivan, A Pandya, G Papadopoulos, D Thompson, A Langston, ... Value in Health 12 (5), 666-673, 2009 | 60 | 2009 |
Cardiovascular disease screening by community health workers can be cost-effective in low-resource countries T Gaziano, S Abrahams-Gessel, S Surka, S Sy, A Pandya, CA Denman, ... Health Affairs 34 (9), 1538-1545, 2015 | 59 | 2015 |
Comparative assessment of absolute cardiovascular disease risk characterization from non-laboratory-based risk assessment in South African populations TA Gaziano, A Pandya, K Steyn, N Levitt, W Mollentze, G Joubert, ... BMC medicine 11, 1-11, 2013 | 58 | 2013 |
Methods of model calibration: observations from a mathematical model of cervical cancer DCA Taylor, V Pawar, D Kruzikas, KE Gilmore, A Pandya, R Iskandar, ... Pharmacoeconomics 28, 995-1000, 2010 | 56* | 2010 |
Comparison of nonblood-based and blood-based total CV risk scores in global populations TA Gaziano, S Abrahams-Gessel, S Alam, D Alam, M Ali, G Bloomfield, ... Global heart 11 (1), 37-46. e2, 2016 | 52 | 2016 |